; (E) serve as the coordinator of ethical, legal, environmental, safety, security, and other appropriate societal input; and (F) promote access to, and early application of, the technologies, innovations, and expertise derived from Initiative activities to agency missions and systems across the Federal Government, and to United States industry, including startup companies. (2) Funding The Director of the Office of Science and Technology Policy shall develop an estimate of the funds necessary to carry out the activities of the Initiative Coordination Office, including an estimate of how much each participating agency described in subsection (a) will contribute to such funds, and submit such estimate to Congress no later than 90 days after the enactment of this Act. (3) Termination The Initiative Coordination Office established under this subsection shall terminate on the date that is 10 years after the date of the enactment of this Act, unless a determination is made by the President that such Office is necessary to meet the economic or national security goals of the Program. 6. Advisory committee (a) In general The President, acting through the Office of Science and Technology Policy, shall designate or establish an advisory committee on engineering biology research and development (in this section referred to as the advisory committee ) to be composed of not fewer than 12 members, including representatives of research and academic institutions, industry, and nongovernmental entities, who are qualified to provide advice on the Initiative. (b) Assessment The advisory committee shall assess— (1) the current state of United States competitiveness in engineering biology, including the scope and scale of United States investments in engineering biology research and development in the international context; (2) current market barriers to commercialization of engineering biology products, processes, and tools in the United States; (3) progress made in implementing the Initiative; (4) the need to revise the Initiative